- βDigital tools improved insulin dosing consistency across most studied trials
- βCGMs and apps led to measurable reductions in HbA1c β the key long-term blood sugar marker
- βBenefits were seen across age groups and in both well-resourced and lower-resource settings
| Journal | BMC endocrine disorders |
| Year | 2025 |
| Authors | Jawad, Afaq, Hussain |
| PMID | 41462455 |
What Was Studied β and Why It Matters
Managing Type 1 diabetes (T1D) is a 24/7 job. Every meal, every dose of insulin, every blood sugar reading requires attention and follow-through. Even with the best intentions, many patients struggle to stick to their routines β a challenge known as treatment adherence. Researchers wanted to know: can digital tools like smartphone apps, continuous glucose monitors (CGMs), and online doctor visits actually help?
A 2025 review published in BMC Endocrine Disorders analyzed 12 high-quality clinical trials from around the world to answer that question.
What the Research Found
Across all 12 studies, digital health tools consistently helped T1D patients do better at managing their condition. Specifically, researchers found improvements in three key areas:
- Insulin administration: Patients using digital tools were more consistent about taking their insulin doses on time and in the right amounts.
- Blood sugar monitoring: People checked their glucose levels more regularly when supported by apps or CGM devices that made tracking easier and more automatic.
- HbA1c levels: This is the 3-month average blood sugar test that doctors use to assess overall diabetes control. Most studies saw meaningful reductions β a sign that day-to-day management was genuinely improving.
The digital tools reviewed included mobile health apps, continuous glucose monitors, telemedicine platforms (virtual doctor visits), and even educational video games designed to teach younger patients about diabetes management.
Why These Tools Work
The review points to a few reasons digital interventions are effective. Real-time feedback is a big one β when a CGM alerts you that your blood sugar is trending high or low, you can act immediately rather than waiting for a scheduled check. Apps that log meals, insulin, and activity create a complete picture that both patients and their care teams can learn from.
Researchers also noted that these tools align with well-established behavior change principles: they educate, build confidence, and provide continuous reinforcement β all of which help people develop lasting healthy habits.
What This Means for Patients
If you or a loved one lives with Type 1 diabetes, this research is encouraging. The right digital tools aren't just convenient β they can genuinely improve your health outcomes. CGM devices in particular stood out as powerful aids for real-time diabetes management.
Having reliable supplies is essential to making these tools work. Whether you use a CGM system or need consistent access to insulin delivery supplies, MDS Diabetes makes it easy to get the diabetes management products you need delivered directly to your door β so technology and supplies work together seamlessly.
The review also highlighted strong potential for digital tools in lower-resource settings, suggesting these solutions could help bridge gaps in diabetes care globally.
Bottom Line
A review of 12 clinical trials confirms that digital health tools β including CGMs, mobile apps, and telemedicine β help Type 1 diabetes patients take their insulin more consistently, monitor blood sugar more often, and achieve better HbA1c results. For T1D patients looking to tighten their management routine, embracing digital tools is a well-supported, practical step forward.